ESC Premium Access

Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension

Event: ESC CONGRESS 2017
Topic: CHF - Non pharmacological treatment
Session type: Satellite Symposium
Organised by Charité Medical School, supported with an educational grant by CVRx
Date: 29 August 2017
Time: 12:45 - 13:45

Session

4 presentations in this session

Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.

Speaker: Professor S. Anker (Berlin, DE)
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Thumbnail

Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

Speaker: Professor A. Pathak (Monaco, MC)
Thumbnail

Resistant hypertension: stimulating the baroreflex when drugs have failed.

Speaker: Professor P. De Leeuw (Maastricht, NL)
Thumbnail

Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?

Speaker: Professor C. Butter (Bernau bei Berlin, DE)
Thumbnail

5 speakers from this session

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
69 presentations
0 follower

Professor Atul Pathak

The Princess Grace Hospital Centre, Monaco (Monaco)
11 presentations
0 follower

Professor Peter W De Leeuw

, Maastricht (Netherlands (The))
3 presentations
0 follower

Professor Christian Butter

Brandenburg Heart Center, Bernau bei Berlin (Germany)
11 presentations
0 follower

This platform is supported by

logo Novo Nordisk